Sphk1/S1P was shown to induce pro-fibrotic factors production by cross-activating the TGF-β/Smad signaling pathway [49], and over-expression of Shpk1 promoted the release of inflammatory factors leading to glomerulosclerosis and interstitial fibrosis [28]. Here, SPHK1 is linked to glomerulosclerosis.